Pediatric Behçet's Disease with Eye Inflammation
Author Information
Author(s): Parentin Fulvio, Lepore Loredana, Rabach Ingrid, Pensiero Stefano
Primary Institution: Institute for Maternal and Child Health Burlo Garofolo
Hypothesis
Can infliximab effectively treat pediatric Behçet's disease with recurrent eye inflammation?
Conclusion
Episcleritis and papillitis are uncommon manifestations of pediatric Behçet's disease, and infliximab is an effective treatment for cases resistant to conventional therapies.
Supporting Evidence
- The patient had recurrent buccal aphthosis and gastrointestinal symptoms.
- The pathergy test was positive, supporting the diagnosis of Behçet's disease.
- Infliximab led to complete resolution of inflammation after the second infusion.
Takeaway
A 12-year-old boy with a rare eye condition got better after receiving a special medicine called infliximab, which helped his eyes heal.
Methodology
The patient was treated with corticosteroids initially, followed by infliximab after recurrent episodes.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
12-year-old Caucasian boy
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website